Visiongain’s publishes new report on the Global Angioplasty Balloons Market 2017-2027
Oct 16, 2017 11:43 am UTC| Business
LONDON, Oct. 16, 2017 -- Angioplasty Balloons – our new study reveals trends, RD progress, and predicted revenues. Where is the Angioplasty Balloons market heading? If you are involved in this sector you must read...
National Vision Announces Launch of its Initial Public Offering
Oct 16, 2017 11:41 am UTC| Business
DULUTH, Ga., Oct. 16, 2017 -- National Vision Holdings, Inc. (“National Vision”) today announced the launch of its initial public offering of 15,800,000 shares of its common stock. The initial public offering price is...
Comvest Capital Announces Investment in Citizens Rx, LLC.
Oct 16, 2017 11:40 am UTC| Business
WEST PALM BEACH, Fla., Oct. 16, 2017 -- Comvest Partners, through its Comvest Capital (“Comvest”) lending strategy, has acted as Documentation Agent on the funding of a Senior Credit Facility (the “Financing”) to...
Visiongain launches new report on the Natural Gas Storage Market 2017-2027
Oct 16, 2017 11:36 am UTC| Business
LONDON, Oct. 16, 2017 -- Volume Forecasts (MCM) by Type of Storage (Above Ground Storage and Underground Storage Facilities) by Technology (LNG Tankers, Salt Caverns, Aquifers, Depleted Oil and Gas Reservoirs Rock...
Oct 16, 2017 11:30 am UTC| Business
B-cell depletion data and MRI data at 24 weeks (6 months) to be presented Abstract data shows complete (100%) elimination of T1 Gd-enhancing lesions at week 24 NEW YORK, Oct. 16, 2017 -- TG Therapeutics, Inc....
Oct 16, 2017 11:30 am UTC| Business
SAN DIEGO, CA, Oct. 16, 2017 -- Global Payout, Inc. (OTCPink: GOHE) (“Global”) is pleased to announce that its majority owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”, the “Company”), in addition to its newly...
TG Therapeutics Announces Completion of Full Enrollment in the UNITY-CLL Phase 3 Trial
Oct 16, 2017 11:30 am UTC| Business
Top-Line ORR data from the UNITY-CLL trial expected in 2Q18 Targeting an NDA/BLA filing for combination of TGR-1202 + TG-1101 in 2H18 NEW YORK, Oct. 16, 2017 -- TG Therapeutics (NASDAQ:TGTX) announced today that it...